Ranbaxy Halts Generic Lipitor Production After Recall

Published: Thursday, November 29th 2012

(Reuters) - Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer Inc's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent recall, the U.S. Food and Drug Administration said on its website.

Read more.

Comment(s)

Your comments are valuable to us. Thank you.

Union Sues Warner Chilcott, Watson and Lupin over Alleged Pay-for-Delay Deal

Ranbaxy to Resume Generic Lipitor Production for U.S.

Pfizer Demands Rehearing in Generic Reglan Case

Pfizer Settles Another Generic Run at Detrol LA

Pfizer Gets Celebrex Patent Extension, Sues Generic Companies